1. Amin MM, Ananth JV, Coleman BS, Darcourt G, Furkas T, Goldstein B, Lapierre YD, Paykel E, Wakelin JS (1984) Fluvoxamine antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 7, Suppl 1: 580–581
2. Angst J, Clayton P (1986) Premorbid personality of depressive, bipolar, and schizophrenic patients with special references to suicidal issues. Compr Psychiatry 27:511–532
3. Asberg, M, Nordström P (1988) Biological correlates of suicidal behavior. In: Möller HJ, Schmidtke A, Welz R (eds) Current issues of suicidology. Springer, Berlin Heidelberg New York Tokyo, pp 221–241
4. Asberg M, Träskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197
5. Asberg M, Bertilsson L, Rydin E, Schalling D, Thorén P, Träskman-Bendz L (1981) Monoamine metabolites in cerebrospinal fluid in relation to depressive illness, suicidal behaviour and personality. In: Angrist B, Burrows, G, Lader M, Lingjaerde O, Sedvall G, Wheatley D (eds) Recent advances in neuropsychopharmacology. Adv Biol Sci 31:257–271